Androgen Effects in HIV-infected Women

Completed · Not applicable · Has a placebo group

Conditions studied: HIV Infection

In brief

Androgen deficiency in HIV-infected women is associated with sarcopenia and may cause critical reductions in physical functioning and reduced bone density. The effects of long-term androgen therapy on lean body mass, bone density and other clinical endpoints including quality of life, functional status and neurocognitive function in HIV-infected women are not known.

Key facts

Study ID
NCT00095212
Run by
Massachusetts General Hospital
People needed
25
Starts
2004-09-01
Expected to finish
2009-02-01
Last updated by the study team
2010-04-14

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.